YWP
BIB icon

YorkBridge Wealth Partners’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

YorkBridge Wealth Partners’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-30
Closed -$2K – 756
2018
Q2 		$2K Hold
30
– – ﹤0.01% 764
2018
Q1 		$2K Hold
30
– – ﹤0.01% 761
2017
Q4 		$2K Hold
30
– – ﹤0.01% 785
2017
Q3 		$2K Buy
+30
New +$1.71K ﹤0.01% 769

Other funds holding BIB

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return
CIC
Chase Investment Counsel Charlottesville, Virginia $381M AUM 69.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BA
BKS Advisors Southfield, Michigan $249M AUM 14.37% 1-Year Est. Return
BRC
Bell Rock Capital Rehoboth Beach, Delaware $81M AUM 9.85% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

YorkBridge Wealth Partners's BIB Position: Q3 2018 in Review

YorkBridge Wealth Partners sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q3 2018, closing a stake of 30 shares — an estimated $2K sold.

YorkBridge Wealth Partners first reported a position in BIB in Q3 2017 and held it in 4 quarters. The position peaked at $2K in Q2 2018. 41 funds tracked by Wall St. Rank hold BIB as of Q3 2018.

  • YorkBridge Wealth Partners reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q3 2018 after selling out during the quarter.
  • YorkBridge Wealth Partners sold 30 ProShares Ultra NASDAQ Biotechnology shares in Q3 2018, an estimated $2K.
  • YorkBridge Wealth Partners first reported a position in ProShares Ultra NASDAQ Biotechnology in Q3 2017 and held it in 4 quarters.
  • YorkBridge Wealth Partners's ProShares Ultra NASDAQ Biotechnology position peaked at $2K in Q2 2018.
  • 41 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q3 2018.

Based on YorkBridge Wealth Partners's 13F filing for Q3 2018, filed 14 Nov 2018.